Paper33166307
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
Siddall H and 7 others. PLoS One, 2020. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study. Papers, record 33166307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33166307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
- PubMed
- Publication types
- Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenine | Major topic |
| Asthma | Major topic |
| Piperidines | Major topic |
| Toll-Like Receptor 7 | Major topic |
| Administration, Intranasal | |
| Adult | |
| Allergens | |
| Anti-Asthmatic Agents | |
| Bronchial Provocation Tests | |
| Double-Blind Method | |
| Female | |
| Forced Expiratory Volume | |
| Humans | |
| Interferon-alpha | |
| Male | |
| Middle Aged | |
| Proof of Concept Study | |
| Rhinitis, Allergic | |
| Young Adult |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02833974 | Effect of the GSK2245035 on the Allergen-induced Asthmatic Response | Background | Yes |
Source ClinicalTrials.gov
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19769993 | Chronic inflammation and asthma. | Mutat Res | 2010 | https://conductscience.org/library/papers/19769993 | PubMed |
| 2 | 25981191 | Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25981191 | PubMed |
| 3 | 30275843 | Asthma. | Allergy Asthma Clin Immunol | 2018 | https://conductscience.org/library/papers/30275843 | PubMed |
| 4 | 15817806 | ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Am J Respir Crit Care Med | 2005 | https://conductscience.org/library/papers/15817806 | PubMed |
| 5 | 21867534 | Treatment of allergic asthma: modulation of Th2 cells and their responses. | Respir Res | 2011 | https://conductscience.org/library/papers/21867534 | PubMed |
| 6 | 28933516 | Anti-IL5 therapies for asthma. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28933516 | PubMed |
| 7 | 26044169 | Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement. | Clin Pharmacol Ther | 2015 | https://conductscience.org/library/papers/26044169 | PubMed |
| 8 | 17400732 | Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. | Am J Respir Crit Care Med | 2007 | https://conductscience.org/library/papers/17400732 | PubMed |
| 9 | 25740945 | TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics. | J Immunol | 2015 | https://conductscience.org/library/papers/25740945 | PubMed |
| 10 | 589783 | Allergen-induced increase in non-allergic bronchial reactivity. | Clin Allergy | 1977 | https://conductscience.org/library/papers/589783 | PubMed |
| 11 | 28681506 | Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial. | Clin Exp Allergy | 2017 | https://conductscience.org/library/papers/28681506 | PubMed |
| 12 | 31856838 | Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study. | Respir Res | 2019 | https://conductscience.org/library/papers/31856838 | PubMed |
| 13 | 26861551 | Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma. | J Med Chem | 2016 | https://conductscience.org/library/papers/26861551 | PubMed |
| 14 | 20224068 | Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. | Am J Respir Crit Care Med | 2010 | https://conductscience.org/library/papers/20224068 | PubMed |
| 15 | 30792118 | Biological treatments for severe asthma: A major advance in asthma care. | Allergol Int | 2019 | https://conductscience.org/library/papers/30792118 | PubMed |
| 16 | 30178633 | Regulatory T cells and asthma. | J Zhejiang Univ Sci B | 2018 | https://conductscience.org/library/papers/30178633 | PubMed |
| 17 | 23125414 | Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist. | J Immunol | 2012 | https://conductscience.org/library/papers/23125414 | PubMed |
| 18 | 17845579 | The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. | Allergy | 2007 | https://conductscience.org/library/papers/17845579 | PubMed |
| 19 | 22561835 | Asthma phenotypes: the evolution from clinical to molecular approaches. | Nat Med | 2012 | https://conductscience.org/library/papers/22561835 | PubMed |
| 20 | 24119772 | Inhaled allergen bronchoprovocation tests. | J Allergy Clin Immunol | 2013 | https://conductscience.org/library/papers/24119772 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42052154 | Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights. | Immun Inflamm | 2026 | https://conductscience.org/library/papers/42052154 | PubMed |
| 39051512 | Dysfunction of dendritic cells in tumor microenvironment and immunotherapy. | Cancer Commun (Lond) | 2024 | https://conductscience.org/library/papers/39051512 | PubMed |
| 37426425 | When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37426425 | PubMed |
| 36964157 | Pathogenesis of allergic diseases and implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36964157 | PubMed |
| 35911708 | The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma. | Front Immunol | 2022 | https://conductscience.org/library/papers/35911708 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33166307
GET https://conductscience.org/api/papers/v1/33166307/references?page=2